Markus Warmuth
President & CEO · Monte Rosa Therapeutics, Inc.
- 2026
- Jul 17, 2026
- 7
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Markus Warmuth files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Filip Janku - $1.38M in GLUE purchases and sales in the last 12 months
- Edmund Dunn - $483K in GLUE purchases and sales in the last 12 months
- Sharon Townson - $424K in GLUE purchases and sales in the last 12 months
- Anthony M. Manning - $411K in GLUE purchases and sales in the last 12 months
- Jennifer Champoux - $311K in GLUE purchases and sales in the last 12 months
- Philip Nickson - $151K in GLUE purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Markus Warmuth?
Markus Warmuth is a corporate insider, tracked as President & CEO of Monte Rosa Therapeutics, Inc. (GLUE). InsiderAlpha holds 7 primary Form 4 filings for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Markus Warmuth submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Markus Warmuth been buying or selling stock?
Recorded transactions: 0 open-market purchases and 10 open-market sales ($951K) across all tracked filings.
